Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 4Unknown 3Terminated 3Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 5Plasma cell 2Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Multiple Myeloma 2Recurrence 1Neoplasms 1

Interventions

Dexamethasone 20daratumumab 17Bortezomib 12Lenalidomide 11pomalidomide 8Cyclophosphamide 8Calcium Dobesilate 7belantamab mafodotin 5isatuximab 4fludarabine 4carfilzomib 4Melphalan 4dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Specimen Handling 3Biopsy 3tocilizumab 2iberdomide 2Stem Cell Transplantation 2Maintenance 2Injections 2Immunotherapy, Adoptive 2Hyaluronoglucosaminidase 2Fluorodeoxyglucose F18 2Exercise Therapy 2Drug Therapy 2CT103A chimeric antigen receptor 2zanubrutinib 1trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Immunotherapy, Adoptive × Plasma cell × Clear all
NCT07612787 2026-05-29

BELAMI

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Not yet recruiting
44 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Recurrence

NCT07458659 2026-03-09

CART-BCMA

Chulalongkorn University

Phase EARLY_PHASE1 Not yet recruiting
3 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡